businesspress24.com - Trials: Pressemitteilungen - Kategorie - Seite 6
 
PresseMitteilungen

Trials

Category / Pharmaceuticals & Biotech / Trials

The Medicines Company Signs Agreement to Acquire ProFibrix

PARSIPPANY, NJ and LEIDEN, THE NETHERLANDS and SEATTLE, WA: Affirms The Medicines Company's Presence in Surgical Hemostasis; ProFibrix Lead Product Fibrocaps Expected to Deliver Phase 3 Data Third Quarter 2013; Highlights The Medicines Company's Long ...

Titan Pharmaceuticals Announces First Quarter 2013 Financial Results

SOUTH SAN FRANCISCO, CA: Titan Management Team to Host Conference Call May 16 at 1:00 p.m. ET / 10:00 a.m. PT ...

Medivation and Astellas Provide Update on PREVAIL

SAN FRANCISCO, CA and TOKYO: Companies Announce Phase 3 PREVAIL Interim Analysis Expected to Occur in 2013 ...

Peregrine Pharmaceuticals Reports Third Quarter Fiscal Year 2013 Financial Results and Recent Developments

TUSTIN, CA: Meaningful Improvement in Median Overall Survival in Patients With Second-Line NSCLC Supports Advancing Bavituximab Into Phase III Development; Contract Manufacturing Revenue Tops $17 Million for Nine ...

Alchemia Granted Key US Patent

BRISBANE, AUSTRALIA: Key US Patent Granted for HyACT Targeted Chemotherapy in Colon Cancer; Extends Monopoly Rights for HA-Irinotecan as Well as Additional Colon Cancer Chemotherapies ...

ICRC-Weyer To Extend Medical Writing And Pharmacovigilance Services

: The German clinical contract research organization (CRO), ICRC-Weyer GmbH, is extending their Medical Writing Services with specialized Pharmacovigilance Writing, a comprehensive solution for regulato ...

Boston Therapeutics Reports Positive Phase ll Clinical Trial Results of PAZ320 in Patients With Type 2 Diabetes

MANCHESTER, NH: PAZ320 Demonstrated 40 Percent Reduction of Post-Meal Blood Glucose Without Serious Adverse Events ...

Clinical CRO ICRC-Weyer To Enhance Pharmacovigilance Risk Management

: The Berlin-based clinical contract research organization (CRO) ICRC-Weyer GmbH is adapting a process of integrating medical review procedures into Pharmacovigilance risk management, a method that will ...

The Medicines Company Announces Positive Results in a Phase 3 Trial of Cangrelor in the Treatment of Patients Undergoing PCI

PARSIPPANY, NJ: CHAMPION PHOENIX Trial Meets Protocol-Specified Predefined Efficacy Endpoint; Intravenous Bolus and Infusion of Cangrelor Provided Statistically Significant Improvement in Ischemic Events at 48 Hours ...

WorldCare Clinical Appoints David Herron to Lead Business Development and Corporate Strategy

BOSTON, MA: Accomplished Executive to Drive Strategies That Support Precision and Accuracy of Clinical Trial Data ...

ICRC-Weyer Clinical CRO Looks Back At A Successful Year 2012

: ICRC-Weyer GmbH, a clinical contract research organization (CRO) based in Berlin, Germany, has released its review of the year 2012, stating it has been a successful and exciting 12 months for everybo ...


Page 6 von 9:   1  2  3  4  5 6 7  8  9 





 

Who is online

All members: 10 667
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 231


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.